Myocardial Infarction and Use of Low-Dose Oral Contraceptives
Author(s) -
Stephen Sidney,
David S. Siscovick,
Diana B. Petitti,
Stephen M. Schwartz,
Charles P. Quesenberry,
Bruce M. Psaty,
Trivellore E. Raghunathan,
Joseph Kelaghan,
Thomas D. Koepsell
Publication year - 1998
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.98.11.1058
Subject(s) - medicine , myocardial infarction , odds ratio , population , diabetes mellitus , risk factor , case control study , endocrinology , environmental health
Population-based case-control studies to assess the relationship of low-dose oral contraceptive (OC) use with myocardial infarction (MI) were performed at 2 sites in the United States (California and Washington state). The purpose of the present study was to estimate risk of MI in relation to use of low-dose OCs in a pooled analysis combining results from the 2 sites.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom